腹膜腔
体腔
平衡
转移
巨噬细胞
腹膜间皮瘤
腹膜
生物
免疫系统
炎症
重编程
癌症研究
自噬
免疫学
医学
病理
间皮瘤
细胞生物学
癌症
细胞凋亡
解剖
内科学
细胞
体外
生物化学
遗传学
作者
Carlos Ardavı́n,Natalia Álvarez Ladrón,Margarita Ferriz,Alejandra Gutiérrez‐González,Adrián Vega‐Pérez
出处
期刊:Advanced Science
[Wiley]
日期:2023-01-19
卷期号:10 (11): e2206617-e2206617
被引量:51
标识
DOI:10.1002/advs.202206617
摘要
Large peritoneal macrophages (LPMs) are long-lived, tissue-resident macrophages, formed during embryonic life, developmentally and functionally confined to the peritoneal cavity. LPMs provide the first line of defense against life-threatening pathologies of the peritoneal cavity, such as abdominal sepsis, peritoneal metastatic tumor growth, or peritoneal injuries caused by trauma, or abdominal surgery. Apart from their primary phagocytic function, reminiscent of primitive defense mechanisms sustained by coelomocytes in the coelomic cavity of invertebrates, LPMs fulfill an essential homeostatic function by achieving an efficient clearance of apoptotic, that is crucial for the maintenance of self-tolerance. Research performed over the last few years, in mice, has unveiled the mechanisms by which LPMs fulfill a crucial role in repairing peritoneal injuries and controlling microbial and parasitic infections, reflecting that the GATA6-driven LPM transcriptional program can be modulated by extracellular signals associated with pathological conditions. In contrast, recent experimental evidence supports that peritoneal tumors can subvert LPM metabolism and function, leading to the acquisition of a tumor-promoting potential. The remarkable functional plasticity of LPMs can be nevertheless exploited to revert tumor-induced LPM protumor potential, providing the basis for the development of novel immunotherapeutic approaches against peritoneal tumor metastasis based on macrophage reprogramming.
科研通智能强力驱动
Strongly Powered by AbleSci AI